Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia

Mehran Karimi; Hadi Bagheri; Fatemeh Rastgu; Eliezer A. Rachmilewitz

doi:10.1160/TH09-09-0661

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 103(05): 989-993
DOI: 10.1160/TH09-09-0661

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia

Mehran Karimi

¹Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

,

Hadi Bagheri

²Radiology Department, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

,

Fatemeh Rastgu

¹Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

,

Eliezer A. Rachmilewitz

³Department of Hematology, The Edith Wolfson Medical Center, Holon, Israel

› Author Affiliations

Abstract

Summary

One complication in patients with β-thalassaemia who had prolonged survival is chronic hypercoagulable state, which results in thromboembolic events involving major organs including the brain. We determined the prevalence of microthrombosis in the brain in an asymptomatic subgroup of patients with β-thalassaemia intermedia (TI) who had undergone splenectomy. This retrospective review included 200 patients with TI diagnosed on the basis of blood count, haemoglobin (Hb) electrophoresis and clinical data. Their ages ranged from 18 to 34 years, 19 (63.3%) were women and 11 (36.7%) were men. We selected 30 patients at random who fulfilled the inclusion criteria: Hb concentration >7 g/dl), splenectomy and platelet count >500,000/ml. Their mean Hb concentration was 8.4 g/dl and their mean ferritin concentration was 519 ng/ml. Magnetic resonance imaging (MRI) was done in every patient, and the findings were interpreted by an expert neuroradiologist. Imaging studies showed pathological findings in 28% of the patients. Six had changes in the white matter suggestive of ischaemia and two had evidence of small infarctions. Conclusion: 1) In this small subset of patients diagnostic magnetic resonance imaging to monitor early asymptomatic or subclinical vascular damage in the brain can be considered when they reach the age of 20 years, and repeated every 3–5 years. 2) Treatment with antiplatelet aggregants is suggested in patients with documented asymptomatic brain ischaemia. 3) These results require confirmation in a larger group of similar patients with other types of thalassaemia who are multitransfused or have an intact spleen.

Keywords

β-thalassaemia intermedia - magnetic resonance imaging - brain ischaemia

Full Text

References

References
1 Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
2 Sébire G, Tabarki B, Saunders DE. et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128: 477-489.
3 Taher A, Abou-Mourad Y, Abchee A. et al. Pulmonary thromboembolism in β-thalassemia intermedia: are we aware of this complication?. Hemoglobin 2002; 26: 107-112.
4 Borgna-Pignatti C, Carnelli V, Caruso V. et. al. Thromboembolic events in β- thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99: 76-79.
5 Cappellini MD, Grespi E, Cassinerio E. et al. Coagulation and splenectomy: an overview. Ann NY Acad Sci 2005; 1054: 317-324.
6 Karimi M, Khanlari M, Rachmilewitz E. A.. Cerebrovascular accident in β-thalassemia major (β-TM) and β-intermedia (β-TI). Am J Hematol 2008; 83: 77-79.
7 Zafeiriou DI, Economou M, Athanasiou-Metaxa M. Neurological complications in beta-thalassemia. Brain Development 2006; 28: 477-481.
8 Manfre L, Giarratano E, Maggio A. et al. MR imaging of the brain: Findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. Am J Roentgenol 1999; 17: 1477-1480.
9 Sinniah D, Vignaendra V, Kamaruddin A. Neurological complications of β-thalassemia major. Arch Dis Child 1977; 52: 977-980.
10 Taher AT, Musallam KM, Nasreddine W. et al. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia inter-media. J Thromb Haemost 2009; 07: 1-6.
11 Cappellini MD, Robbiolo L, Bottasso BM. et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467-473.
12 Goldschmidt N, Spectre G, Brill A. et al. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells. Thromb Haemost 2008; 100: 864-870.
13 Cohen AR, Galanello R, Pennell DJ. et al. Thalassemia. Hematology. Am Soc Hematol Educ Program 2004; 01: 14-34.
14 Tripatara A, Jetsrisuparb A, Teeratakulpisarn J. et al. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassaemia/hemoglobin E disease. Thromb Res 2007; 120: 805-810.
15 Carvalho KS, Bodensteiner JB, Connolly PJ. et al. cerebral venous thrombosis in children. J Child Neurol 2000; 16: 574-580.
16 Incorpora G, Di Gregorio F, Romeo MA. Focal neurological deficits in children with beta-thalassemia major. Neuropediatrics 1999; 30: 45-48.
17 Taher A, Mehio G, Isma’eel H. et al. Stroke in thalassemia: A dilemma. Am J Hematol 2008; 83: 343.
18 Agarwal R, Sze G. Neuro-lyme disease: MR imaging findings. Radiology 2009; 253: 167-173.